Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2–Low A double-blind placebo-controlled phase III trial ...
An artist’s conception shows the Space Systems Command’s SpaceDEN facility. (U.S. Space Force Illustration) Seattle-based Integrate says it has raised $3.4 million in funding and secured a $1.25 ...
DENVER, GLOBAL, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Integrate, the leader in B2B Precision Demand Marketing (“PDM”), today announced a majority investment from Audax Private Equity (“Audax”). This ...
Leader in B2B precision demand marketing, Integrate, has announced its launch of its Demand Acceleration Platform to centralise and connect the B2B buying experience. Integrate’s DAP provides a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results